Treatment of small cell lung cancer (2003 update);Traitement du cancer bronchique à petites cellules (CBPC)

Revue des Maladies Respiratoires

Volumn 21, Issue 1, 2004, Pages 171-174

  Mennecier, B ^a   Dansin, E ^b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Centre Anti Cancéreux   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ERYTHROPOIETIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; PACLITAXEL; TOPOTECAN; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CONFERENCE PAPER; DRUG EFFICACY; EVOLUTION; HUMAN; IRRADIATION; LUNG SMALL CELL CANCER; MEDIASTINUM; QUESTIONNAIRE; SIDE EFFECT; TOXICITY; TREATMENT OUTCOME;

EID: 1842764852     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(04)71254-1     Document Type: Conference Paper

References (10)

1. Simon GR, Wagner H: Small cell lung cancer. Chest 2003; 123: 259S-271S.
2. Pujol JL, Carestia L, Daures JP: Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br Cancer 2000; 83: 8-15.
3. Mascaux C, Paesmans M, Berghmans T, Branle F, Lafitte JJ, Lemaitre F, Meert AP, Vermylen P, Sculier JP: A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000; 30: 23-36.
4. Tjan-Heijnen VC, Wagener DJ, Postmus PE: An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn. Ann Oncol 2002; 13: 1519-30.
5. Sculier JP, Berghmans T, Castaigne C, Luce S, Sotiriou C, Vermylen P, Paesmans M: Maintenance chemotherapy for small cell lung cancer: a critical review of the literature. Lung Cancer 1998; 19: 141-51.
6. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327: 1618-24.
7. Fried DB, Morris DE, Hensing TA, Poole C, Halle JS, Rosenman JG, Socinski MA: A meta-analysis evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small cell lung cancer. Int J Radiat Oncol Biol Phys 2003; 57: S139-40.
8. Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T, Fukuda H, Saijo N: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002; 20: 3054-60.
9. Berghmans T, Paesmans M, Lafitte JJ, Mascaux C, Meert AP, Sculier JP: Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis. Lung Cancer 2002; 37: 115-23.
10. Chin R Jr, McCain TW, Miller AA, Dunagan DP, Acostamadiedo J, Douglas Case L, Harkness BA, Adler LP, Haponik EF: Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study. Lung Cancer 2002; 37: 1-6.